Y-mAbs Therapeutics, Inc.
YMAB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $67 | $79 | $106 | $182 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $20 | $22 | $13 | $8 |
| Inventory | $7 | $5 | $7 | $6 |
| Other Curr. Assets | $4 | $5 | $5 | $7 |
| Total Curr. Assets | $99 | $111 | $130 | $202 |
| Property Plant & Equip (Net) | $1 | $2 | $2 | $6 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $2 | $3 | $3 | $2 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $18 | $12 | $6 | $3 |
| Total NC Assets | $21 | $17 | $11 | $11 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $120 | $128 | $141 | $213 |
| Liabilities | – | – | – | – |
| Payables | $7 | $6 | $14 | $14 |
| Short-Term Debt | $1 | $2 | $1 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $16 | $12 | $13 | $13 |
| Total Curr. Liab. | $24 | $20 | $28 | $28 |
| LT Debt | $0 | $1 | $1 | $2 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $4 | $6 | $3 | $3 |
| Total NC Liab. | $4 | $7 | $4 | $5 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $2 | $4 |
| Total Liabilities | $28 | $27 | $32 | $33 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$487 | -$457 | -$436 | -$340 |
| AOCI | $2 | $0 | $1 | $1 |
| Other Equity | $577 | $558 | $544 | $519 |
| Total Equity | $92 | $101 | $109 | $180 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $120 | $128 | $141 | $213 |
| Net Debt | -$66 | -$76 | -$104 | -$178 |